Meeting NewsVideo

VIDEO: Eyenovia's microdosing technology promising for treating progressive myopia

CHICAGO — At the Ophthalmology Innovation Summit at the American Academy of Ophthalmology meeting, Sean Ianchulev, MD, MPH, president and CEO of Eyenovia,discusses the company’s microdosing technology for the treatment of progressive myopia.

CHICAGO — At the Ophthalmology Innovation Summit at the American Academy of Ophthalmology meeting, Sean Ianchulev, MD, MPH, president and CEO of Eyenovia,discusses the company’s microdosing technology for the treatment of progressive myopia.

    See more from Ophthalmology Innovation Summit